Navigation Links
SNM releases new fact sheet on breast cancer and molecular imaging
Date:10/3/2008

RESTON, Va.Coinciding with the observance of Nuclear Medicine Week (October 5 to 11) and National Breast Cancer Awareness Month (October), SNM released today a new fact sheet highlighting recent developments in molecular imaging technologies that are dramatically improving the ways in which breast cancer is diagnosed and treated.

Molecular imaging is a highly effective, safe and painless imaging tool for diagnosing and treating breast cancer. Physicians report that the information they have gained from molecular imaging technologies has resulted in decisions to change the course of treatment in between 24 and 48 percent of breast cancer cases.

Breast cancer is just one of many types of cancer for which new and emerging molecular imaging techniques and therapies can significantly improve detection, diagnosis and treatment.

"As a field, molecular imaging is evolving very rapidly," said SNM President Robert W. Atcher, Ph.D., M.B.A. "Each new discoverywhether through improved cancer diagnosis and treatment, increased understanding of the fundamental causes of Alzheimer's disease or strides in how we treat cardiovascular diseasebrings personalized medicine one step closer to reality. Molecular imaging techniques and therapies allow us to understand what is happening at a cellular level. Physicians can actually see the precise location of disease, determine if other organs are being affected and then target treatment. It is about delivering the right treatment to the right patient at the right time."

Molecular imaging has the power to:

  • Diagnose cancer early onat its most curable stage;
  • Create a portrait of what cells are doing and how they function over time;
  • Eliminate the need for unnecessary exploratory surgery or multiple surgeries;
  • Provide a painless and cost-effective alternative to more expensiveand less accuratediagnostic tests;
  • Confirm and treat suspected recurrent cancers;
  • Monitor an individual's response to treatment and make adjustments as necessary;
  • Equip physicians and individuals with information to make informed decisions about the best courses of action.

"Molecular imaging has the ability to detect abnormalities very early in the progression of disease, or even before symptoms occurpotentially saving countless lives," added Atcher. "Working together with patients and their caregivers, we can truly imagine the future."


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related biology news :

1. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
2. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
3. EPA releases report on climate change and health
4. EPA releases science assessment on health effects of nitrogen oxides
5. Pioneering landscape-scale research releases first findings
6. Wildlife Conservation Society releases definitive state of the wild
7. DOE JGI releases a new version of its metagenome data management and analysis system
8. DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts
9. WHRC releases 4 key reports
10. University of Minnesota releases first ever comprehensive report of the health of college students
11. Toxic releases down from North American industry leaders, increasing from other facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... PUNE, India , March 23, 2017 The report ... Equipment, Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by ... growing at a CAGR of 29.63% between 2017 and 2022. ... ... Logo ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic ... time. A recent study published in STEM CELLS suggests that human neural stem ... stem cells to produce more neural cells. , Strategies involving transplantation of ...
(Date:3/28/2017)... 28, 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: ... compelling safety and clinical data from its phase 1/2 tendon ... hair follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... ... safety profile at 6 months and showed no serious adverse ...
(Date:3/27/2017)... WARREN, N.J. , March 27, 2017 Roka ... providing advanced testing solutions for the detection of foodborne pathogens, ... at the Sidoti & Company Spring 2017 Convention on March ... the New York Marriott Marquis. About Roka ... ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... cancer (mCRC) generally produce small, heterogeneous samples with limited tumor content in a ... remain to be resolved, such as the need for reliable detection of low ...
Breaking Biology Technology: